Efficient method for the quantitation of urinary leukotriene E-4: Extraction using an Empore C-18 disk cartridge

被引:27
作者
Mita, H [1 ]
Oosaki, R [1 ]
Mizushima, Y [1 ]
Kobayashi, M [1 ]
Akiyama, K [1 ]
机构
[1] TOYAMA MED & PHARMACEUT UNIV,DEPT INTERNAL MED 1,TOYAMA 93001,JAPAN
来源
JOURNAL OF CHROMATOGRAPHY B | 1997年 / 692卷 / 02期
关键词
leukotrienes;
D O I
10.1016/S0378-4347(97)00006-6
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
We describe here an efficient procedure for the precise quantitation of leukotriene E-4 (LTE4) in a small volume of urine, which was achieved mainly by the use of an Empore extraction disk cartridge. After addition of [H-3]LTE4 to 2 mi of urine, an Empore C-18 cartridge was used for initial extraction of the urine, which resulted in the extraction of LTE4 in a small volume of solvent. The eluate could then be injected onto a high-performance liquid chromatography column without further concentration. After separation by high-performance liquid chromatography, LTE4 was extracted from the effluent using an Empore C-18 cartridge. The concentration of LTE4 was subsequently quantified by enzyme immunoassay. LTE4 can be recovered from urine with sufficient efficiency (69.9+/-4.7%, mean+/-S.D., n=101). The coefficient of variation of the assay procedure was less than 10%. When urine was spiked with different amounts of LTE4, the recovery of LTE4 added to the urine specimen was less than 120%. The concentration of LTE4 in urine from normal healthy subjects was 48.0+/-15.3 pg/mg creatinine (n=15).
引用
收藏
页码:461 / 466
页数:6
相关论文
共 24 条
[1]   ENHANCED EXCRETION OF URINARY LEUKOTRIENE-E(4) IN CORONARY-ARTERY DISEASE AND AFTER CORONARY-ARTERY BYPASS-SURGERY [J].
ALLEN, SP ;
SAMPSON, AP ;
PIPER, PJ ;
CHESTER, AH ;
OHRI, SK ;
YACOUB, MH .
CORONARY ARTERY DISEASE, 1993, 4 (10) :899-904
[2]   DIURNAL-VARIATION OF URINARY LEUKOTRIENE E(4) AND HISTAMINE EXCRETION RATES IN NORMAL SUBJECTS AND PATIENTS WITH MILD-TO-MODERATE ASTHMA [J].
ASANO, K ;
LILLY, CM ;
ODONNELL, WJ ;
ISRAEL, E ;
FISCHER, A ;
RANSIL, BJ ;
DRAZEN, JM .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1995, 96 (05) :643-651
[3]   PERSISTENT GENERATION OF PEPTIDO LEUKOTRIENES IN PATIENTS WITH THE ADULT RESPIRATORY-DISTRESS SYNDROME [J].
BERNARD, GR ;
KORLEY, V ;
CHEE, P ;
SWINDELL, B ;
FORDHUTCHINSON, AW ;
TAGARI, P .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1991, 144 (02) :263-267
[4]   URINARY LEUKOTRIENE-E4 CONCENTRATIONS INCREASE AFTER ASPIRIN CHALLENGE IN ASPIRIN-SENSITIVE ASTHMATIC SUBJECTS [J].
CHRISTIE, PE ;
TAGARI, P ;
FORDHUTCHINSON, AW ;
CHARLESSON, S ;
CHEE, P ;
ARM, JP ;
LEE, TH .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1991, 143 (05) :1025-1029
[5]  
DENZLINGER C, 1986, J BIOL CHEM, V261, P5601
[6]   ENHANCED SYNTHESIS OF CYSTEINYL LEUKOTRIENES IN JUVENILE RHEUMATOID-ARTHRITIS [J].
FAULER, J ;
THON, A ;
TSIKAS, D ;
VONDERHARDT, H ;
FROLICH, JC .
ARTHRITIS AND RHEUMATISM, 1994, 37 (01) :93-97
[7]   METABOLISM OF CYSTEINYL LEUKOTRIENES IN MONKEY AND MAN [J].
HUBER, M ;
MULLER, J ;
LEIER, I ;
JEDLITSCHKY, G ;
BALL, HA ;
MOORE, KP ;
TAYLOR, GW ;
WILLIAMS, R ;
KEPPLER, D .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1990, 194 (01) :309-315
[8]  
HUBER M, 1989, EUR J CLIN INVEST, V19, P53, DOI 10.1111/j.1365-2362.1989.tb00195.x
[9]   THE PIVOTAL ROLE OF 5-LIPOXYGENASE PRODUCTS IN THE REACTION OF ASPIRIN-SENSITIVE ASTHMATICS TO ASPIRIN [J].
ISRAEL, E ;
FISCHER, AR ;
ROSENBERG, MA ;
LILLY, CM ;
CALLERY, JC ;
SHAPIRO, J ;
COHN, J ;
RUBIN, P ;
DRAZEN, JM .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1993, 148 (06) :1447-1451
[10]  
KNAPP HR, 1992, J LAB CLIN MED, V119, P48